Wednesday, February 10, 2010, 7:07pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

ULURU Inc. (ULU)

At 5:00AM SGT: 0.1795 USD   0.00 (0.00%)  
 MORE ON ULU 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 ULURU INC (AMEX:ULU) Delayed quote dataEdit
Last Trade:0.1795 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:0.1795
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:N/A
Day's Range:N/A - N/A
52wk Range:0.10 - 0.49
Volume:0
Avg Vol (3m):2,608,390
Market Cap:11.86M
P/E (ttm):N/A
EPS (ttm):-0.159
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
Use Y! Toolbar to track stocks
 Add ULU to Portfolio   Download Data

 HEADLINES 
•ULURU INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
EDGAR Online (Wed, Feb 3)
•ULURU Inc. to Raise $1.0 Million in Registered Direct 'At The Market' Offering
PR Newswire (Wed, Feb 3)
•ULURU Inc. Invited to Present at Research and New Ventures Forum on Nanomedicine
PR Newswire (Thu, Jan 21)
•ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference
PR Newswire (Wed, Dec 9)
•ULURU Inc. Obtains Status of Approved Supplier With McKesson.
PR Newswire (Thu, Dec 3)
•ULURU INC. Financials
EDGAR Online Financials (Sun, Nov 22)
•ULURU INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Tue, Nov 17)
•ULURU Inc. Reports Third Quarter 2009 Financial Results
PR Newswire (Tue, Nov 17)
•ULURU INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Tue, Nov 17)
•ULURU Inc. to Raise $1.5 Million in Registered Direct Offering
PR Newswire (Thu, Nov 12)
More Headlines for ULU...
 ANALYST 
EPS Est (next year) (Jan-70) :N/A
EPS Est (in 2 years) (Jan-70) :N/A
Avg Rec (current)*:2.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Uluru Inc., a pharmaceutical company, engages in the research, development, and commercialization of wound management and oral care products worldwide.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices